je.st
news
Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference
2015-04-02 18:23:24| Logistics - Topix.net
Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that Validive phase II clinical trial results have been accepted for a poster presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology . The ASCO annual meeting is a major event in the field of oncology that brings together 30,000 health professionals and updates on the major latest steps and results achieved in oncology worldwide.
Tags: the
results
presented
trial
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||